IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11744887 B1

PDFFull Text
Date of Patent:
Sep. 05, 2023

Filed:

Mar. 09, 2021

Coronavirus vaccine compositions and methods

Applicant:

Arcturus Therapeutics, Inc., San Diego, CA (US);

Inventors:

Sean Michael Sullivan, Escondido, CA (US);

Daiki Matsuda, San Diego, CA (US);

Kiyoshi Tachikawa, San Diego, CA (US);

Padmanabh Chivukula, San Diego, CA (US);

Priya Prakash Karmali, San Diego, CA (US);

Jared Henry Davis, Poway, CA (US);

Yanjie Bao, San Diego, CA (US);

Amit Sagi, San Diego, CA (US);

Assignee:

ARCTURUS THERAPEUTICS, INC., San Diego, CA (US);

Attorney:

Mintz, Levin, Cohn, Ferris Glovsky and Popeo, P.C.

Primary Examiner:

Rachel B Gill

Int. Cl.
CPC ...
A61K 39/215 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01); A61K 47/20 (2006.01); A61K 47/26 (2006.01); A61K 47/10 (2017.01); A61K 9/51 (2006.01); A61K 39/12 (2006.01); C07K 14/18 (2006.01); C12N 7/00 (2006.01); A61K 39/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/215 (2013.01); A61K 9/5123 (2013.01); A61K 39/12 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/26 (2013.01); C07K 14/005 (2013.01); C07K 14/1808 (2013.01); C12N 7/00 (2013.01); C12N 15/86 (2013.01); A61K 38/00 (2013.01); A61K 2039/53 (2013.01); C12N 2770/20022 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/36122 (2013.01); C12N 2770/36134 (2013.01); C12N 2830/42 (2013.01); C12N 2830/50 (2013.01);
Abstract

Provided herein are nucleic acid molecules encoding viral replication proteins and antigenic coronavirus proteins or fragments thereof. Also provided herein are compositions that include nucleic acid molecules encoding viral replication and antigenic proteins, and lipids. Nucleic acid molecules provided herein are useful for inducing immune responses.

Find Patent Forward Citations

Loading…